Clobetasol Propionate

Specifications

25122-46-7CAS Number

246-634-3EC Number

[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoateIUPAC Name

C25H32ClFO5Chemical Formula

467 g/molMolecular Weight

CLOBETASOL PROPIONATE; 25122-46-7; Clobetasol 17-propionate; Clobex; Dermovate; Temovate; Embeline; Cormax; Olux; Embeline E; Temovate E; Olux-E; Impoyz; Psorex; CCI 4725; GR 2/925; clobetasol 17-propanoate; Olux E; Clarelux; Dovate; [(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate; DTXSID6045907; Clobetasol propionate gel; CCI-4725; IMPEKLO; CLOBETASOL PROPIONATE (EMOLLIENT); Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11beta,16beta)-; NSC-758634; GR-2/925; DTXCID4025907; CHEBI:31414; 21-chloro-9-fluoro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate; 779619577M; Clobetavix; Clobaderm; Etrivex; Clodan; Dermovate nn; ((8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta(a)phenanthren-17-yl) propanoate; RefChem:5696; Clobetasol 17 Propionate; Clobetasol Propionate ANDA; Clobetasol Propionate Cream; Tovet (emollient formulation); Clobetasol Propionate, Hydrocolloid; Clobetasol Propionate USP, 0.05%; Clobetasol Propionate Cream, 0.05%; Clobetasol Propionate Ointment, 0.05%; Clobetasol Propionate Cream USP, 0.05%; Clobetasol Propionate Emollient Formulation; Clobetasol Propionate Ointment USP, 0.05%; Clobetasol Propionate Cream, 0.05% Clobetasol Propionate Cream, 0.05%; Clobetasol Propionate Cream USP, 0.05% Clobetasol Propionate Cream USP, 0.05%; 21-Chloro-9-fluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propanoate; C25H32ClFO5; MFCD00058499; 21-Chloro-9-fluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate; MLS000028708; SMR000058745; MLS001076345; Clobetasol-17-propionate; Clobesol; Dermoxinale; Butavate; Dermoval; Yugofin; Clobetasolpropionate; (11beta,16beta)-21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione; CGP 9555; EINECS 246-634-3; NCGC00095078-01; Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11.beta.,16.beta.)-; clobetasol-propionate; CAS-25122-46-7; Clobex (TN); Cormax (TN); UNII-779619577M; Clobetasol propionate [USAN:USP:JAN]; Olux (TN); Clobetasol propionate E; Opera_ID_1470; Clobetasol propionate CRS; SCHEMBL3997; 21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione (11beta,16beta)-; cid_32798; GTPL7062; CHEMBL1159650; Clobetasol propionate (Standard); BDBM39347; MSK2237; CBGUOGMQLZIXBE-XGQKBEPLSA-N; CLOBETASOL PROPIONATE [MI]; HMS2090A04; HMS2230H08; HMS3259A10; HMS3714M04; Clobetasol propionate (JP18/USP); CLOBETASOL PROPIONATE [JAN]; (8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate; CLOBETASOL PROPIONATE [USAN]; Tox21_111414; Clobetasol propionate [EP monograph]; CLOBETASOL PROPIONATE [VANDF]; EBC-27167; HY-13600R; MSK2237-100A; s2584; CLOBETASOL PROPIONATE [MART.]; AKOS015951278; CLOBETASOL PROPIONATE [USP-RS]; CLOBETASOL PROPIONATE [WHO-DD]; MSK2237-1000A; Tox21_111414_1; CCG-220781; CLOBETASOL 17-PROPIONATE [MI]; DB01013; FC20489; NC00551; NSC 758634; 21-Chloro-9-fluoro-11beta-hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate; NCGC00023373-03; NCGC00023373-04; NCGC00023373-09; (1R,2S,3aS,3bS,9aS,9bR,10S,11aS)-1-(2-chloroacetyl)-9b-fluoro-10-hydroxy-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl propanoate; AC-17990; AS-12555; Clobetasol propionate, analytical standard; CPD000058745; HY-13600; Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-beta,17-dihydroxy-16-beta-methyl-, 17-propionate; SY060191; CLOBETASOL PROPIONATE [ORANGE BOOK]; CLOBETASOL PROPIONATE [USP IMPURITY]; C2612; C4659; CLOBETASOL PROPIONATE [USP MONOGRAPH]; NS00000111; D01272; AB00383081-10; AB00383081_11; EN300-7480850; Q421637; SR-01000000280; SR-01000000280-4; BRD-K10799896-001-10-6; BRD-K10799896-001-24-7; BRD-K10799896-001-26-2; Clobetasol 17-propionate Solution in Acetonitrile, 1000ug/mL; Clobetasol 17-propionate Solution in Acetonitrile, 100ug/mL; Clobetasol propionate, European Pharmacopoeia (EP) Reference Standard; Clobetasol propionate, United States Pharmacopeia (USP) Reference Standard; Clobetasol for peak identification, European Pharmacopoeia (EP) Reference Standard; Clobetasol Propionate, Pharmaceutical Secondary Standard; Certified Reference Material; (11?,16?)-21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione; (11|_,16|_)-21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione; (8alpha,11beta,14beta,16alpha,17alpha)-21-chloro-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate; 21-Chloro-9alpha-fluoro-11beta,17alpha-dihydroxy-16beta-methyl-1,4-pregnadiene-3,20-dione 17-Propionate; Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11|A,16|A)-; XRDSynonyms